Ken Griffin’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79M | Buy |
1,674,041
+195,406
| +13% | +$9.22M | 0.01% | 363 |
|
|
2025
Q1 | $57.8M | Sell |
1,478,635
-708,231
| -32% | -$27.7M | 0.01% | 427 |
|
|
2024
Q4 | $118M | Sell |
2,186,866
-136,105
| -6% | -$7.37M | 0.02% | 229 |
|
|
2024
Q3 | $117M | Buy |
2,322,971
+57,276
| +3% | +$2.89M | 0.02% | 189 |
|
|
2024
Q2 | $99.6M | Sell |
2,265,695
-43,738
| -2% | -$1.92M | 0.02% | 245 |
|
|
2024
Q1 | $116M | Buy |
2,309,433
+300,773
| +15% | +$15.1M | 0.02% | 204 |
|
|
2023
Q4 | $121M | Sell |
2,008,660
-25,736
| -1% | -$1.55M | 0.02% | 189 |
|
|
2023
Q3 | $116M | Buy |
2,034,396
+13,788
| +0.7% | +$786K | 0.02% | 193 |
|
|
2023
Q2 | $103M | Sell |
2,020,608
-902,830
| -31% | -$46M | 0.02% | 222 |
|
|
2023
Q1 | $62.5M | Buy |
2,923,438
+37,346
| +1% | +$799K | 0.01% | 369 |
|
|
2022
Q4 | $30.3M | Buy |
2,886,092
+200,155
| +7% | +$2.1M | 0.01% | 670 |
|
|
2022
Q3 | $21.4M | Sell |
2,685,937
-16,724
| -0.6% | -$133K | ﹤0.01% | 782 |
|
|
2022
Q2 | $13.9M | Buy |
2,702,661
+2,003,765
| +287% | +$10.3M | ﹤0.01% | 1059 |
|
|
2022
Q1 | $7.76M | Buy |
698,896
+12,959
| +2% | +$144K | ﹤0.01% | 1647 |
|
|
2021
Q4 | $6.6M | Hold |
685,937
| – | – | ﹤0.01% | 1856 |
|
|
2021
Q3 | $6.77M | Sell |
685,937
-5,794
| -0.8% | -$57.2K | ﹤0.01% | 1785 |
|
|
2021
Q2 | $7.15M | Sell |
691,731
-1,636
| -0.2% | -$16.9K | ﹤0.01% | 1767 |
|
|
2021
Q1 | $7.07M | Buy |
693,367
+6,289
| +0.9% | +$64.2K | ﹤0.01% | 1729 |
|
|
2020
Q4 | $7.44M | Buy |
+687,078
| New | +$7.44M | ﹤0.01% | 1457 |
|